Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1804 of 5804
-
New pill could help PAD patients walk longer without pain
Symptom relief Recruiting nowThe purpose of this study is to evaluate the effect and safety of orforglipron once daily in participants with Fontaine II peripheral arterial disease (PAD). Participation in the study will last about 58 weeks.
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Symptom relief
Last updated Jul 19, 2026 00:00 UTC
-
Blood plasma boost for laser acne scar treatment?
Symptom relief Recruiting nowThis randomized controlled trial aims to evaluate whether adding platelet-rich plasma (PRP) to fractional CO₂ laser resurfacing improves the treatment of moderate-to-severe acne scars compared with laser alone. Seventy adults aged 18-40 years will be recruited from the Dermatolog…
Phase: NA • Sponsor: Gujranwala medical college District Headquarters Hospital, Gujranwala • Aim: Symptom relief
Last updated Jun 27, 2026 08:13 UTC
-
One pill to rule them all? triple diabetes combo under study
Disease control Recruiting nowThe efficacy and safety of a triple-pill combination therapy for advanced type 2 diabetes care. The study aims to assess the impact of 3 Oral Anti Diabetic (OAD) drugs on metabolic control, patient compliance, weight management, quality of life, diabetic treatment satisfaction an…
Phase: PHASE4 • Sponsor: Nabiqasim Industries (Pvt) Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
Heart artery showdown: one device vs. custom toolkit for stent success
Disease control Recruiting nowSome patients with coronary artery disease have severely calcified vessels. In these cases, placing a stent - a small tube that helps keep the artery open - can be very difficult. Calcium build-up in the artery wall may prevent the stent from expanding properly, increasing the ri…
Phase: NA • Sponsor: IHF GmbH - Institut für Herzinfarktforschung • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New pill could ease swallowing for EoE patients
Disease control OngoingThe primary objective of this study is to assess the efficacy of vonoprazan 20 mg once daily (QD) compared to placebo QD in the number of participants with a peak eosinophilic histologic response \<15 eosinophils per high-power field (eos/hpf) after 12 weeks of therapy.
Phase: PHASE2 • Sponsor: Phathom Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Smartphone app could save babies after heart surgery
Disease control Recruiting nowWe hypothesize that a home monitoring program combined with routine postoperative care significantly reduces morbidity and mortality after neonatal and pediatric cardiac surgery. This project differs from the previously published experiences by (a) providing an innovative telemed…
Phase: NA • Sponsor: Nantes University Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New scan could spot hidden thyroid cancers without needle biopsy
Diagnosis Not yet recruitingTo assess the clinical significance of FDG-avid thyroid incidentalomas detected on PET/CT and explore correlations between SUV max, ultrasound characteristics, and histopathology for suspicious lesion.
Sponsor: Fatma Abelzaher Mahmoud Ahmed • Aim: Diagnosis
Last updated Jun 27, 2026 07:52 UTC
-
Diabetes drug metformin takes on leukemia gene
Disease control Not yet recruitingThis is a prospective, single-arm clinical study evaluating the efficacy and safety of metformin in inhibiting DNMT3A R882-driven clonal hematopoiesis (CH) in patients with acute leukemia (AL) who are in remission and under follow-up. Patients with DNMT3A R882 mutation (VAF ≥5%) …
Phase: PHASE1 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
AI learns to read Children's breathing in the ER
Knowledge-focused Recruiting nowThis is a multicenter, prospective observational study designed to collect clinical data for the development of a vision-language model-based artificial intelligence system for automated assessment of pediatric respiratory patterns. The study enrolls pediatric patients aged 0 to…
Sponsor: Samsung Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:04 UTC
-
Nerve-zapping procedure for high blood pressure put to the test in medicare patients
Disease control Recruiting nowThis observational study will assess the long-term effectiveness of the RDN procedure for lowering blood pressure in Medicare patients with uncontrolled hypertension. This research will be conducted using de-identified electronic health records (EHR) and administrative health ins…
Sponsor: Medtronic Vascular • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New ultrasound aims to see bladder cancer more clearly before surgery
Diagnosis Recruiting nowThe project will include 30 patients with bladder cancer who are candidates for bladder removal. After signing the consent form, the study team will collect some clinical data, such as age, past medical history, past surgical history, and information about your current disease. …
Sponsor: Duke University • Aim: Diagnosis
Last updated Jun 27, 2026 12:29 UTC
-
Robot hip device aims to improve walking after stroke
Symptom relief CompletedThe aim of this study is to evaluate the safety of gait training using a hip-assist powered exoskeleton. This will be assessed by collecting all device-related adverse events occurring during the entire intervention period, which consists of a total of 10 sessions within 5 weeks …
Phase: NA • Sponsor: Samsung Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Can a simple cloth pad transform menstrual health for millions?
Disease control OngoingOver 50% of Bangladeshi women and girls use old cloths as menstrual absorbents due to cost, comfort, and familiarity. A substantial proportion, comprising 52% of adolescent girls and 62% of women washed the cloths with soap and water. However, more than 60% dried it in hiding ins…
Phase: NA • Sponsor: International Centre for Diarrhoeal Disease Research, Bangladesh • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
New once-nightly pill may ease narcolepsy symptoms in kids
Symptom relief Recruiting nowThe main objectives of this study are to determine the treatment preferences of children with narcolepsy type 1 between Extended-release sodium oxybate and Non-extended-release oxybates (Sodium oxybate or a medication with the combination of Calcium, magnesium, potassium, and sod…
Phase: PHASE2 • Sponsor: Stanford University • Aim: Symptom relief
Last updated Jun 27, 2026 07:56 UTC
-
Simple blood test could predict breast cancer return
Knowledge-focused Recruiting nowFor patients with breast cancer, it's important to find any remaining cancer cells after they've had their main treatment. Even a few cells, called minimal residual disease (MRD), can lead to the cancer coming back later. A way to find these cells is by looking for tiny bits of …
Sponsor: Tempus AI • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
New eye drop aims to lower glaucoma pressure
Disease control CompletedPhase 2 Study of BL1107 Eye Drops vs. Timolol in Adults with Primary Open Angle Glaucoma or Ocular Hypertension
Phase: PHASE2 • Sponsor: Bausch & Lomb Incorporated • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
New syringe could make eye injections easier for macular degeneration patients
Disease control CompletedThis is a phase 3, open-label study to evaluate the safety of pegcetacoplan in a prefilled syringe (PFS)
Phase: PHASE3 • Sponsor: Apellis Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New drug miRisten targets Tough-to-Treat leukemia in early trial
Disease control TerminatedThis phase I trial tests the safety, side effects, and best dose of miRisten in treating patients with acute myeloid leukemia (AML) that has come back after a period of improvement (relapsed) or that has not responded to previous treatment (refractory). MiRisten may stop the grow…
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Gut bacteria byproducts may tame inflammation and shield the brain
Knowledge-focused Recruiting nowShort-chain fatty acids (SCFAs) are substances produced by gut bacteria when they ferment dietary fiber. They can act as signals between the gut and the brain and may help regulate the body's immune and stress responses. Earlier work has shown that delivering SCFAs to the colon c…
Phase: NA • Sponsor: Universitaire Ziekenhuizen KU Leuven • Aim: Knowledge-focused
Last updated Jul 22, 2026 00:00 UTC
-
New bone graft could cut infection in severe leg breaks
Disease control Recruiting nowOpen pilon fractures are challenging problems to manage. Infection rates vary from 6-30% and metaphyseal nonunion varies from 7-20%. The current recommendation for the management of open pilon fractures with bone loss is a staged approach, with internal fixation around an antibio…
Sponsor: University of Missouri-Columbia • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC